Immunotherapy versus tyrosine kinase inhibitors in advanced hepatocellular carcinoma in first-line setting: A systematic review and meta-analysis of randomized controlled trials

被引：0
|
作者：
Carolina Marin Comini, Ana Carolina
de Sousa, Isadora Martins
Abrahao Reis, Pedro Cotta
Carvalho, Bruno Murad
Guedes Camandaroba, Marcos Pedro
机构：
[1] AC Camargo Canc Ctr, Sao Paulo, Brazil
[2] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil
[3] Fac Med Barbacena FAME FUNJOB, Lavras, Brazil
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16132
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Safety and efficacy of tyrosine kinase inhibitors for the treatment of multiple sclerosis: A systematic review and meta-analysis from randomized controlled trials
    Yan, Zeya
    Gu, Feng
    Wang, Zilan
    Meng, Jiahao
    Tao, Xinyu
    Dai, Qiling
    Wang, Wei
    Liu, Meirong
    Wang, Zhong
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [42] Transarterial chemoembolization (TACE) plus tyrosine kinase inhibitors versus TACE in patients with hepatocellular carcinoma: a systematic review and meta-analysis
    Duan, Ruihua
    Gong, Fen
    Wang, Yan
    Huang, Caixia
    Wu, Jiaming
    Hu, Leihao
    Liu, Min
    Qiu, Shijun
    Lu, Liming
    Lin, Yisheng
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [43] Transarterial chemoembolization (TACE) plus tyrosine kinase inhibitors versus TACE in patients with hepatocellular carcinoma: a systematic review and meta-analysis
    Ruihua Duan
    Fen Gong
    Yan Wang
    Caixia Huang
    Jiaming Wu
    Leihao Hu
    Min Liu
    Shijun Qiu
    Liming Lu
    Yisheng Lin
    World Journal of Surgical Oncology, 21
  • [44] Efficacy of First Line Systemic Chemotherapy and Multikinase Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis
    Oranratnachai, Songporn
    Rattanasiri, Sasivimol
    Pooprasert, Anantaporn
    Tansawet, Amarit
    Reungwetwattana, Thanyanan
    Attia, John
    Thakkinstian, Ammarin
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [45] First-line targ veted therapies of advanced hepatocellular carcinoma: A Bayesian network analysis of randomized controlled trials
    Ding, Wei
    Tan, Yulin
    Qian, Yan
    Xue, Wenbo
    Wang, Yibo
    Jiang, Peng
    Xu, Xuezhong
    PLOS ONE, 2020, 15 (03):
  • [46] Comparative efficacy and safety of first-line tyrosine kinase inhibitors in chronic myeloid leukemia: a systematic review and network meta-analysis
    Zhang, Jing-Jing
    Qian, Yu-Lan
    Wu, Zi-Yang
    Li, Yue
    Guan, Ying-Jie
    Sun, Cui
    Fu, Kai-Li
    Mei, Tong-Lin
    Goyal, Gaurav
    Bernasconi, Paolo
    Damiani, Daniela
    Zhu, Jian-Guo
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (07)
  • [47] Comparative efficacy and safety of transarterial chemoembolization combined with tyrosine kinase inhibitors and immune checkpoint inhibitors versus tyrosine kinase inhibitors and immune checkpoint inhibitors alone in advanced hepatocellular carcinoma: a systematic review and meta-analysis
    Hengyu Tian
    Chidan Wan
    World Journal of Surgical Oncology, 23 (1)
  • [48] The role of immunotherapy plus chemotherapy versus chemotherapy alone as first-line treatment for advanced non-small cell lung cancer: an updated systematic review and meta-analysis of randomized controlled trials
    Abdelazeem, Basel
    Abbas, Kirellos Said
    Labieb, Fatma
    Arida, Abdul Karim
    El-Shahat, Nahla Ahmed
    Shehata, Joseph
    Kandah, Emad
    Malik, Bilal
    Akanbi, Maxwell
    Rafae, Abdul
    Wahab, Ahsan
    Ehsan, Hamid
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (10) : 1127 - 1140
  • [49] A NETWORK META-ANALYSIS OF FIRST-LINE SYSTEMIC THERAPIES FOR ADVANCED HEPATOCELLULAR CARCINOMA
    Singh, B.
    Sharma, A.
    Rai, P.
    Kaur, G.
    Pandey, S.
    VALUE IN HEALTH, 2023, 26 (06) : S26 - S26
  • [50] Efficacy and safety of lenvatinib versus sorafenib in first-line treatment of advanced hepatocellular carcinoma: A meta-analysis
    Luo, Jia
    Gao, Benjian
    Lin, Zhiyu
    Fan, Hua
    Ma, Wen
    Yu, Danfei
    Yang, Qian
    Tian, Jing
    Yang, Xiaoli
    Li, Bo
    FRONTIERS IN ONCOLOGY, 2022, 12
12345